Vanguard Capital Management’s Precision BioSciences DTIL Stock Holding History
Bought
Maintained
Sold
Other funds holding DTIL
LCM
Vanguard Capital Management's DTIL Position: Q3 2026 in Review
Vanguard Capital Management reduced its Precision BioSciences (DTIL) stake by 1.2% in Q3 2026, selling an estimated $101K and leaving 1,102,925 shares worth $6.9M. The position accounts for ﹤0.01% of the portfolio, ranked #2962.
Vanguard Capital Management first reported a position in DTIL in Q1 2026 and has held it in 3 quarters since. The position peaked at $8.77M in Q2 2026. 109 funds tracked by Wall St. Rank hold DTIL as of Q3 2026.
- Vanguard Capital Management held 1,102,925 shares of Precision BioSciences worth $6.9M as of Q3 2026.
- Vanguard Capital Management sold 13,316 Precision BioSciences shares in Q3 2026, an estimated $101K.
- Precision BioSciences made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #2962 holding.
- Vanguard Capital Management first reported a position in Precision BioSciences in Q1 2026 and has held it in 3 quarters since.
- Vanguard Capital Management's Precision BioSciences position peaked at $8.77M in Q2 2026.
- 109 funds tracked by Wall St. Rank held Precision BioSciences as of Q3 2026.
Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.